CN115778847B - Jelly-like eye shadow and preparation method thereof - Google Patents
Jelly-like eye shadow and preparation method thereof Download PDFInfo
- Publication number
- CN115778847B CN115778847B CN202211660883.XA CN202211660883A CN115778847B CN 115778847 B CN115778847 B CN 115778847B CN 202211660883 A CN202211660883 A CN 202211660883A CN 115778847 B CN115778847 B CN 115778847B
- Authority
- CN
- China
- Prior art keywords
- eye shadow
- oil
- jelly
- powder
- mica
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 73
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000002562 thickening agent Substances 0.000 claims abstract description 26
- 239000010445 mica Substances 0.000 claims abstract description 25
- 229910052618 mica group Inorganic materials 0.000 claims abstract description 25
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 18
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 18
- 239000004519 grease Substances 0.000 claims abstract description 15
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229910001887 tin oxide Inorganic materials 0.000 claims abstract description 15
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 14
- 239000003381 stabilizer Substances 0.000 claims abstract description 12
- 239000003906 humectant Substances 0.000 claims abstract description 11
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims description 21
- 235000010215 titanium dioxide Nutrition 0.000 claims description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 16
- 229920001577 copolymer Polymers 0.000 claims description 16
- 229920002148 Gellan gum Polymers 0.000 claims description 12
- -1 di-decyl tetradecyl Chemical group 0.000 claims description 12
- 239000000216 gellan gum Substances 0.000 claims description 12
- 235000010492 gellan gum Nutrition 0.000 claims description 12
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 8
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 8
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 claims description 8
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 8
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 8
- 229940113124 polysorbate 60 Drugs 0.000 claims description 8
- 229940057429 sorbitan isostearate Drugs 0.000 claims description 8
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 5
- 240000000912 Macadamia tetraphylla Species 0.000 claims description 5
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- 230000003078 antioxidant effect Effects 0.000 claims description 4
- 229940008099 dimethicone Drugs 0.000 claims description 4
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 claims description 3
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical group [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 235000019482 Palm oil Nutrition 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 3
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 3
- 239000004359 castor oil Substances 0.000 claims description 3
- 235000019438 castor oil Nutrition 0.000 claims description 3
- 239000003240 coconut oil Substances 0.000 claims description 3
- 235000019864 coconut oil Nutrition 0.000 claims description 3
- 239000002270 dispersing agent Substances 0.000 claims description 3
- 239000003974 emollient agent Substances 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
- 239000008169 grapeseed oil Substances 0.000 claims description 3
- 229940049290 hydrogenated coco-glycerides Drugs 0.000 claims description 3
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 3
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 3
- 229940119170 jojoba wax Drugs 0.000 claims description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 3
- 239000010466 nut oil Substances 0.000 claims description 3
- 229940049964 oleate Drugs 0.000 claims description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 239000002540 palm oil Substances 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- 239000003813 safflower oil Substances 0.000 claims description 3
- 235000005713 safflower oil Nutrition 0.000 claims description 3
- 229940057910 shea butter Drugs 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 235000002639 sodium chloride Nutrition 0.000 claims description 3
- 235000020238 sunflower seed Nutrition 0.000 claims description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 3
- 229960000281 trometamol Drugs 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 241001506047 Tremella Species 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 2
- 238000004040 coloring Methods 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 17
- 235000015110 jellies Nutrition 0.000 abstract description 9
- 239000008274 jelly Substances 0.000 abstract description 9
- ULGYAEQHFNJYML-UHFFFAOYSA-N [AlH3].[Ca] Chemical compound [AlH3].[Ca] ULGYAEQHFNJYML-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003973 paint Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 description 23
- 239000007788 liquid Substances 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 14
- 230000006641 stabilisation Effects 0.000 description 12
- 238000011105 stabilization Methods 0.000 description 12
- 238000011049 filling Methods 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 239000002245 particle Substances 0.000 description 7
- 230000003020 moisturizing effect Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000001804 emulsifying effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical group OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001673966 Magnolia officinalis Species 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229940087068 glyceryl caprylate Drugs 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- 210000000216 zygoma Anatomy 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- FKIQSOGFDBALHA-UHFFFAOYSA-L aluminum trimagnesium potassium dioxido(oxo)silane oxygen(2-) difluoride Chemical compound [O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[K+].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O FKIQSOGFDBALHA-UHFFFAOYSA-L 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 206010015915 eye discharge Diseases 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 239000004482 other powder Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Polymers [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
The application discloses a jelly-shaped eye shadow and a preparation method thereof, wherein the jelly-shaped eye shadow comprises the following components in percentage by mass: 10% -18% of pearl powder, which comprises at least one of calcium aluminum borosilicate, calcium sodium borosilicate and mica; a coloring powder, 5% -12%, comprising titanium dioxide powder, tin oxide, iron oxide black, at least part of the surface of which is coated with silica; 0.5% -3% of aqueous thickener; 0.2% -1% of skin-moistening grease; oil-in-water type emulsifier, 0.02-0.2% stabilizer, 0.02% -0.3%; 4% -6% of humectant; 65% -78% of water. The water-based thickener, the skin-moistening grease, the oil-in-water type emulsifier and the water in proper proportion uniformly disperse the pearl powder and the coloring powder, so that the effect of shining when the paint is less can be achieved; the eye shadow forms a jelly shape, does not drip water after application, and avoids stains caused by dripping after use.
Description
Technical Field
The application belongs to the technical field of daily cosmetics, and particularly relates to a jelly-shaped eye shadow and a preparation method thereof.
Background
Eye shadow is a cosmetic applied to the upper eyelid and the tail of the eye, and has high saturation, and can make the eye look like concave-convex.
Common eye shadows are generally powdery and ointments. The eye shadow of the powder is easy to fly, the ointment is sticky and greasy, and Yi Ka is in a line, so that the experience of consumers is reduced. In addition, in the use process, after the eye shadow of the powder and the ointment falls, stains are easily caused at clothes and the like, so that the improvement of the eye shadow is needed.
Disclosure of Invention
In view of the above, the application provides a jelly-like eye shadow and a preparation method thereof, and aims to provide a new formulation of fresh and non-sticky eye shadow.
In a first aspect, embodiments of the present application provide a jelly-like eye shadow, including the following components in percentage by mass:
10% -18% of pearl powder, which comprises at least one of calcium aluminum borosilicate, calcium sodium borosilicate and mica;
a coloring powder, 5% -12%, comprising titanium dioxide powder, tin oxide, iron oxide black, at least part of the surface of which is coated with silica;
0.5% -3% of aqueous thickener;
0.2% -1% of skin-moistening grease;
oil-in-water type emulsifier, 0.02-0.2%
0.02% -0.3% of stabilizer;
4% -6% of humectant;
65% -78% of water.
According to an embodiment of one aspect of the present application, the pearlescent powder comprises 80% to 92% sodium calcium borosilicate and 8% to 20% mica, based on the total weight of the pearlescent powder.
According to an embodiment of one aspect of the present application, the colored powder comprises 35% -45% titanium dioxide dust having a portion of its surface coated with silica, based on the total weight of the colored powder.
According to an embodiment of one aspect of the present application, the aqueous thickener is selected from gellan gum, carrageenan, PEG-240/HDI copolymer bis-decyl tetradecyl polyether-20 ether or a combination thereof.
According to an embodiment of one aspect of the present application, the aqueous thickener comprises 60% -75% gellan gum, based on the total weight of the aqueous thickener.
According to an embodiment of one aspect of the present application, the mass ratio of gellan gum to PEG-240/HDI copolymer bis-decyl tetradecyl polyether-20 ether is (25-32): 50, optionally 29.94:50.
according to an embodiment of one aspect of the present application, the oil-in-water emulsifier is selected from hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, polysorbate-60, sorbitan isostearate or a combination thereof.
According to an embodiment of one aspect of the present application, the mass ratio of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, polysorbate-60, sorbitan isostearate is (42-46): 2-4): 3, optionally 44:3:3.
According to an embodiment of an aspect of the present application, the emollient oil is selected from the group consisting of polydimethylsiloxane, ethyl macadamia nut oleate, hydrogenated cocoglycerides, glycerol laurate, isononyl isononanoate, hydrogenated polyisobutylene, sunflower seed oil, safflower seed oil, jojoba oil, castor oil, coconut oil, grape seed oil, shea butter, white pool seed oil, macadamia nut oil, olive oil, palm oil, or a combination thereof.
According to an embodiment of an aspect of the present application, the preservative is selected from phenoxyethanol, octylglycol, sodium benzoate, glyceryl caprylate, anisoic acid, magnolia bark extract, or a combination thereof.
According to an embodiment of an aspect of the present application, the humectant is selected from glycerin, propylene glycol, 1, 3-butylene glycol, trehalose, tremella polysaccharide, magnetitum lock, sodium hyaluronate, or a combination thereof.
According to an embodiment of an aspect of the present application, the stabilizer is selected from anhydrous calcium chloride, potassium laurate, magnesium sulfate, sodium chloride, potassium chloride, tromethamine, triethanolamine, or a combination thereof.
According to an embodiment of an aspect of the present application, the jelly-like eye shadow further comprises 0.5% -1.5% of a powder dispersing agent and/or 0.02% -0.3% of an antioxidant.
In a second aspect, an embodiment of the present application provides a method for preparing a jelly-like eye shadow, including:
providing a component and a component content of an eye shadow according to the first aspect;
preparing a filling material: mixing and dispersing 10% -18% of pearl powder and 5% -12% of coloring powder to obtain uniform filling material;
preparing a functional material in a liquid state: mixing 0.5-3% of water-based thickener, 0.2-1% of skin-moistening grease, 0.02-0.2% of oil-in-water type emulsifier, 0.02-0.3% of stabilizer, 4-6% of humectant and 65-78% of water at a preset temperature to obtain a functional material in a liquid state;
preparing an eye shadow: mixing and emulsifying the filling material and the functional material in a liquid state to obtain the eye shadow;
optionally, the preparation of the filler is performed simultaneously with the preparation of the functional material in the liquid state.
Compared with the prior art, the application has the following beneficial effects:
the eye shadow provided by the embodiment of the application comprises pearl powder, coloring powder, an aqueous thickener, skin-moistening grease, an oil-in-water type emulsifier and the like, wherein part of the surface of the pearl powder and the surface of the coloring powder are coated with silica to cooperatively lighten the titanium dioxide powder, so that the lightening effect of the eye shadow is improved, and the pearl powder and the coloring powder have good dispersibility after being doped with the silica, so that the color is more uniform, and the powder is not agglomerated; the water-based thickener, the skin-moistening grease, the oil-in-water type emulsifier and the water in proper proportion uniformly disperse the pearl powder and the coloring powder, so that the effect of shining when the paint is less can be achieved; the eye shadow forms a jelly shape, does not drip water after application, and avoids stains caused by dripping after use.
Drawings
FIG. 1 shows a jelly-like eye shadow of an embodiment;
figure 2 shows a comparative non-jelly-like eye shadow.
Detailed Description
In order to make the application purposes, technical solutions and beneficial technical effects of the present application clearer, the present application is further described in detail below with reference to examples. It should be understood that the embodiments described in this specification are for purposes of illustration only and are not intended to limit the present application.
For simplicity, only a few numerical ranges are explicitly disclosed in this application. However, any lower limit may be combined with any upper limit to form a range not explicitly recited; and any lower limit may be combined with any other lower limit to form a range not explicitly recited, and any upper limit may be combined with any other upper limit to form a range not explicitly recited. Furthermore, each point or individual value between the endpoints of the range is included within the range, although not explicitly recited. Thus, each point or individual value may be combined as a lower or upper limit on itself with any other point or individual value or with other lower or upper limit to form a range that is not explicitly recited.
In the description of the present application, unless otherwise indicated, "above" and "below" are intended to include the present number, and the meaning of "multiple" in "one or more" means two or more.
The above summary of the present application is not intended to describe each disclosed embodiment or every implementation of the present application. The following description more particularly exemplifies illustrative embodiments. Guidance is provided throughout this application by a series of embodiments, which may be used in various combinations. In the various examples, the list is merely a representative group and should not be construed as exhaustive.
Eye shadow is a make-up cosmetic which is applied to the eyelid and canthus to create shadows and contrast in hue, giving rise to a three-dimensional aesthetic appearance. Eye shadow formulations are similar to foundations, but are more colorful and tend to have additional gloss, typically with the addition of various coloring and pearlescent powders. Thus, in the prior art, the main dosage forms of eye shadow are solid powdery eye shadow and liquid-pasty eye shadow.
In the related art, a solid powdery eye shadow is easy to fly powder, a liquid-paste eye shadow is sticky and greasy, and the solid powdery eye shadow is easy to clamp into a line after a certain period of make-up.
The inventor provides an eye shadow with jelly texture through intensive thinking and a large number of experiments, and solves the problems that powder eye shadow is easy to fly and ointment eye shadow is easy to clamp eye line.
Jelly-like eye shadow
The first aspect of the embodiments of the present application provides a jelly-like eye shadow, which comprises the following components in percentage by mass:
10% -18% of pearl powder, which comprises at least one of calcium aluminum borosilicate, calcium sodium borosilicate and mica;
a coloring powder, 5% -12%, comprising titanium dioxide powder, tin oxide, iron oxide black, at least part of the surface of which is coated with silica;
0.5% -3% of aqueous thickener;
0.2% -1% of skin-moistening grease;
oil-in-water type emulsifier, 0.02-0.2%
0.02% -0.3% of stabilizer;
4% -6% of humectant;
65% -78% of water.
According to the embodiment of the application, the jelly-like eye shadow comprises components such as pearlescent powder, coloring powder, an aqueous thickener, skin-moisturizing grease, an oil-in-water type emulsifier and the like, and the eye shadow with the jelly texture is free from fading and dripping after being immediately made up, and is free from stains and smudges in the use process.
According to the embodiment of the application, the jelly-like eye shadow is jelly-like and has no slicing property, and can not be easily crashed when external force is applied. However, when the jelly-like eye shadow is put into a 200ml container with about 100g and is shaken up and down by about 10 times, the jelly-like eye shadow collapses and is partially crushed. Irregular colloidal blocks having a degree of tackiness, neither a soft liquid nor a solid. Such as a smooth-surfaced medium, e.g., glass, clothing, metal, and the like, a portion of which can be removed without mark, and thus no stain is generated during use.
In some embodiments, the jelly-like eye shadow further comprises a powder of one or more of silica, talc, and polymethylsilsesquioxane. Illustratively, by adding silica powder, the eye shadow can have a certain concealing force, can increase the smooth feel of the skin, make the skin smooth and make the skin look like, and can enhance the overall dispersibility of other powder in the eye shadow to avoid agglomeration.
In some embodiments, the pearlescent powder comprises 80% to 92% sodium calcium borosilicate and 8% to 20% mica, based on the total weight of the pearlescent powder.
By way of example, synthetic fluorophlogopite may be selected for use in the present application. As an example, the sodium calcium borosilicate can increase the sparkling luster of the eye shadow, has a blurring effect and a light protection effect, and can effectively achieve the effect of halation; in addition, the sodium calcium borosilicate has a low oil absorption effect, can effectively regulate sebum secretion grease, and improves the persistence of eye shadow. The sodium calcium borosilicate can also effectively weaken wrinkles and flaws, so that the skin color is more uniform.
In some embodiments, the colored powder comprises 35% to 45% titanium dioxide dust having a portion of the surface coated with silica, based on the total weight of the colored powder.
According to the embodiment of the application, the titanium dioxide powder with part of the surface wrapped by the silica is adopted, the dispersibility of the coloring powder and the dispersibility of the pearl powder are improved by adding the silica, and at the same time, the natural light sensation of eye shadow is improved
In some embodiments, the colored powder is selected from titanium dioxide, iron oxide yellow, iron oxide red, tin oxide, iron oxide black, polydimethylsiloxane-modified titanium dioxide, and aluminum hydroxide-modified red 30, or a combination thereof.
According to the embodiment of the application, the stability of the color of the eye shadow is enhanced by adding the organic coloring powder and the inorganic coloring powder in different ways, and the natural light sensation of the eye shadow is enhanced by adding the tin oxide.
In some implementations, the average particle size (D50) of the pearlescent powder and the colored powder are each independently 10-100um. The pearlescent powder and the coloring powder with different particle sizes can lead the eye shadow to present different blazing effects.
The desired particle size can be obtained by conventional methods, for example by sieving or sedimentation. The average particle diameter (D50) was measured by a Markov particle diameter analyzer (model: mastersizer 3000 laser diffraction particle size analyzer) instrument from Markov.
In some embodiments, the colored powder has particles of about 20 to about 40 μm.
In some embodiments, the jelly-like eye shadow comprises a first mica pearlescent mixture composed of mica, titanium dioxide, iron oxide black, the mass ratio of mica, titanium dioxide, and iron oxide black being 43:7:50.
in some embodiments, the jelly-like eye shadow comprises a second mica pearlescent mixture, the second mica pearlescent mixture consisting of mica, titanium dioxide, tin oxide, the mass ratio of mica, titanium dioxide, tin oxide being 34:65.5:0.5.
in some embodiments, the jelly-like eye shadow comprises a glass pearlescent mixture consisting of calcium sodium borosilicate: titanium white powder: tin oxide, sodium calcium borosilicate: titanium white powder: the mass ratio of the tin oxide is 87.9:10.7:1.4.
in some embodiments, the pearlescent powder and the colored powder in jelly-like eye shadows are comprised of a first mica pearlescent mixture, a second mica pearlescent mixture, and a glass pearlescent mixture.
In some embodiments, the jelly-like eye shadow comprises 1% -2% of the first mica pearlescent mixture, 2% -3% of the second mica pearlescent mixture, and 16% -17% of the glass pearlescent mixture.
According to the embodiment of the application, the pearlescent powder and the coloring powder with proper mass ratio are combined, so that the pearlescent effect of the eye shadow can be improved, and the eye shadow can be better in brightening and anti-darkening effects; the pearlescent powder and the coloring powder with proper mass ratio are synergistic, and have the effects of improving the saturation of eye shadow, the concave-convex feeling and the shining luster.
In some embodiments, the aqueous thickener is selected from gellan gum, carrageenan, PEG-240/HDI copolymer bis-decyl tetradecyl polyether-20 ether, or a combination thereof.
According to the embodiment of the application, the thickening agent plays an important role in thickening, stability and rheological property of the oil-in-water jelly-like eye shadow; by using the thickener, it is possible to give it a good consistency, as well as excellent spreadability and extensibility. By adding the thickener, the viscosity of the oil-in-water emulsion can be adjusted, and the skin adhesion and the use feeling can be enhanced. The thickener can increase the viscosity of the system and has the emulsifying effect.
In some embodiments, the aqueous thickener comprises 60% to 75% gellan gum, based on the total weight of the aqueous thickener. The gellan gum with the weight ratio is utilized to form jelly-like eye shadow.
In some embodiments, the mass ratio of gellan gum to PEG-240/HDI copolymer bis-decyl tetradecyl polyether-20 ether is (25-32): 50, optionally 29.94:50. by adding the thickener in the above ratio, a jelly-like eye shadow can be provided with a relatively stable gel.
In some embodiments, the oil-in-water emulsifier is selected from hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, polysorbate-60, sorbitan isostearate, or a combination thereof.
According to the embodiment of the application, the emulsifier can provide excellent emulsifying effect, can mix oil and water together to form emulsion, or forms jelly shape under the matching of other components, so that the emulsifier has excellent dispersibility and stability, is fresh and comfortable in use, has no greasy feel, and has good consistency, and excellent spreadability and ductility.
In some embodiments, the mass ratio of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, polysorbate-60, sorbitan isostearate is (42-46): 2-4): 3, optionally 44:3:3. The above mass range can promote the components in eye shadow to form jelly shape, and promote the stability and transportation of the components.
In some embodiments, the emollient oil is selected from the group consisting of dimethicone, ethyl macadamia oleate, hydrogenated cocoglycerides, glycerol laurate, isononyl isononanoate, hydrogenated polyisobutylene, sunflower seed oil, safflower seed oil, jojoba oil, castor oil, coconut oil, grape seed oil, shea butter, white pool seed oil, macadamia nut oil, olive oil, palm oil, or a combination thereof.
According to the embodiment of the application, the types of the skin-moisturizing grease are not particularly limited, the oil phase component can be selected according to the needs, the skin permeability is good, the effect of increasing loose softness of the eye shadow is good, and the moisturizing, fluidity, repairability and extensibility of the eye shadow can be further improved by matching with other components, and the moisturizing and skin-adhering effects of the eye shadow are ensured.
Illustratively, the polydimethylsiloxane can increase the color degree, reduce the gloss, control and absorb sebum, adjust the viscosity, increase the smooth feel, have the extremely powdery texture, do not seal pores and improve the dispersibility of the powder.
In some embodiments, the preservative is selected from phenoxyethanol, octylglycol, sodium benzoate, glyceryl caprylate, anisoic acid, magnolia bark extract, or a combination thereof. The preservative can be well compatible with other substances, and the service life of eye shadow can be prolonged and the shelf life can be prolonged by adding the preservative.
In some embodiments, the humectant is selected from Xin Ganyou, ethylhexyl dimethicone, phenyl dimethicone, cetyl dimethicone, diisostearate malate, or combinations thereof.
According to the embodiment of the application, the moisturizing agent has strong moisturizing performance, can absorb moisture from the environment and supplement the moisture to the skin, can further improve the moisturizing effect of jelly-shaped eye shadow, keeps the jelly shape, and is also beneficial to moisturizing the deep skin of the jelly-shaped eye shadow.
In some embodiments, the stabilizer is selected from anhydrous calcium chloride, potassium laurate, magnesium sulfate, sodium chloride, potassium chloride, tromethamine, triethanolamine, or combinations thereof. By adding the stabilizer, jelly-like stability can be improved.
In some embodiments, the jelly-like eye shadow further comprises 0.5% -1.5% powder dispersant and/or 0.02% -0.3% antioxidant. According to the embodiment of the application, the antioxidant can reduce oxidation of coloring powder, reduce color change of eye shadow and improve the makeup holding performance of the eye shadow; it also can combat harmful free radicals, which can damage the skin, such as vitamin C can combat free radicals, and can improve the overall appearance of the skin.
Preparation method of jelly-like eye shadow
In a second aspect, an embodiment of the present application provides a method for preparing a jelly-like eye shadow, including:
providing a component and a component content of an eye shadow according to the first aspect;
preparing a filling material: mixing and dispersing 10% -18% of pearl powder and 5% -12% of coloring powder to obtain uniform filling material;
preparing a functional material in a liquid state: mixing 0.5-3% of water-based thickener, 0.2-1% of skin-moistening grease, 0.02-0.2% of oil-in-water type emulsifier, 0.02-0.3% of stabilizer, 4-6% of humectant and 65-78% of water at a preset temperature to obtain a functional material in a liquid state;
preparing an eye shadow: mixing and emulsifying the filling material and the functional material in a liquid state to obtain the jelly-shaped eye shadow;
optionally, the preparation of the filler is performed simultaneously with the preparation of the functional material in the liquid state. In some embodiments, the preparation of the filler is performed simultaneously with the preparation of the functional material in the liquid state. The purpose of improving efficiency can be achieved.
In some embodiments, the predetermined temperature is 30-150 ℃, alternatively 50-100 ℃. The adhesive can be brought into a liquid state while being mixed with the vegetable fat.
According to the embodiment of the application, by controlling the stirring speed, each component can be uniformly dispersed, and meanwhile, the dispersing efficiency is provided; the raw materials can be saved by collecting and utilizing the attachments attached to the container, and the mass ratio of each component can be fully controlled.
Examples
The following examples more particularly describe the disclosure of the present application, which are intended as illustrative only, since numerous modifications and variations within the scope of the disclosure will be apparent to those skilled in the art. Unless otherwise indicated, all parts, percentages, and ratios reported in the examples below are by weight, and all reagents used in the examples are commercially available or were obtained synthetically according to conventional methods and can be used directly without further treatment, as well as the instruments used in the examples.
Examples 1 to 3
The jelly-like eye shadow comprises the following components in percentage by mass:
10% -18% of pearl powder, which comprises at least one of calcium aluminum borosilicate, calcium sodium borosilicate and mica;
a coloring powder, 5% -12%, comprising titanium dioxide powder, tin oxide, iron oxide black, at least part of the surface of which is coated with silica;
0.5% -3% of aqueous thickener;
0.2% -1% of skin-moistening grease;
oil-in-water type emulsifier, 0.02-0.2%
0.02% -0.3% of stabilizer;
4% -6% of humectant;
65% -78% of water.
The components and the content of the components in the examples are shown in Table 1.
The preparation method of the jelly-like eye shadow comprises the following steps:
providing materials according to the components and the component contents of the eye shadow;
preparing a filling material: mixing and dispersing 10% -18% of pearl powder and 5% -12% of coloring powder to obtain uniform filling material;
preparing a functional material in a liquid state: mixing 0.5-3% of water-based thickener, 0.2-1% of skin-moistening grease, 0.02-0.2% of oil-in-water type emulsifier, 0.02-0.3% of stabilizer, 4-6% of humectant and 65-78% of water at a preset temperature to obtain a functional material in a liquid state;
preparing an eye shadow: and mixing and emulsifying the filling material and the functional material in a liquid state to obtain the jelly-shaped eye shadow.
Checking the color and uniformity, and repeating the above operation once if the color and uniformity are not satisfactory; and transferring the material body into a container for light-shielding preservation after meeting the requirements.
TABLE 1
Comparative examples 1 to 7
The present comparative example provides an eye shadow, which is different in that: the eye shadow was prepared in the same manner as in example 1, except that the composition and the content of the composition were different. Comparative examples the components and the content of the components are shown in Table 2.
TABLE 2
/>
Performance detection
1) Patch test
30 persons (5 men, 25 women) were withdrawn, aged 18 to 60 years, and the following conditions should be excluded from the subjects.
The preparation method comprises the steps of (1) making a pregnant woman or a lactating woman.
And (5) extremely sensitive skin.
The antihistaminic or immunosuppression has been within one month for one week.
Taking the patch part of the anti-inflammatory medicine within 2 months.
The subject does not treat inflammatory skin disorders.
The subject is insulin for diabetes habit.
Asthma or CRD subjects are undergoing treatment.
Cancer is cured within 6 months after chemotherapy.
Autoimmune diseases.
And bilateral axillary lymph node resection bilateral mastectomy.
Those operating in the same or similar profession.
Those traces, blemishes or moles are in the test area.
Those that are not willing to participate in the test or cannot complete the test as required.
The patch test is carried out by the specific method: the eye shadow prepared in the example was applied to the front inner side of the arm in an amount of 0.2g, the applied skin area was 2cm×2cm, and skin reaction results were recorded over 0.5h, 24h and 48h, as shown in table 3.
Table 3 patch test results.
None of the 30 persons tested according to the above had an allergic reaction to the product, which was suitable for most consumers.
2) Observation of eye shadow state changes of embodiments
The change in eye shadow prepared in the examples was observed and the results are shown in table 4 below.
Project | Example 1 | Example 2 | Example 3 |
For 1 day | Stabilization | Stabilization | Stabilization |
For 7 days | Stabilization | Stabilization | Stabilization |
14 days | Stabilization | Stabilization | Stabilization |
1 month | Stabilization | Stabilization | Stabilization |
As shown in table 4, examples 1 to 3 were also stable after one month of preparation by observing the stability of the eye shadow of examples and comparative examples at room temperature for one month.
Comparative examples 2 to 6 did not produce the jelly-like shape of the present application, and at 7 days, the eye shadow state was changed and unstable. In comparative examples 3-4, separation was observed after 14. The reason for the jelly-like separation phenomenon in the comparative example is that a suitable oil-in-water emulsifier was not added.
As shown in fig. 1, in the example, it was confirmed that the eye shadow was not dropped and that a part also remained in a jelly shape without falling off.
As shown in fig. 2, in comparative example 3, a large amount of smears were shown immediately after use, comparative example 2 was not fixed during spraying, and the liquid flowed downward, thus confirming that it was not equipped with jelly shape.
3) Sensory evaluation experiment
The experimental object: healthy Chinese females with 25-45 years old in the same area, no obvious wounds and diseases and dry cheekbone parts are recruited, 20 females are recruited in each experimental group, and the experimental results are averaged and rounded.
The experimental method comprises the following steps:
experimental group: the face was cleaned 8 a.m., and then 0.2g of the eye shadow of the examples and comparative examples was applied to the cheek bone area of the right cheek.
Scoring rules: the subjects scored the following parameters, respectively:
third dimension grading: has better stereoscopic impression, is marked as '1', and has poorer stereoscopic impression as '0'.
Scoring the darkness: after 5.5 hours of making up on the eye shadow, observing whether the eye shadow has a dark condition, wherein the eye shadow is marked as '1' without dark condition and the eye shadow is marked as '0' without dark condition;
the degree of dripping is scored by using 0.2ml of eye shadow on a 45 degree incline from the plane of the skin when the eye shadow is applied to the skin, to see if there is a degree of eye shadow slipping or dripping. No drop is '1' and sliding or drop is '0';
make-up holding degree experiment:
after the application of the experimental object is completed, running is carried out by adopting a running machine at 35 ℃, the running speed is 10km/h, and after running for 10min, the experimental object has sweating; rest for 10min after running for 20 min; after 3h, stopping movement, observing the makeup removal condition, and dividing the makeup removal condition into 10 parts according to the higher score if the makeup removal degree is smaller; the higher the degree of makeup removal, the lower the score.
TABLE 4 Table 4
The eye shadow of examples 1-3 had good three-dimensional effect, was anti-darkening, and the jelly-like eye shadow was not dropped, and the eye shadow was excellent in makeup-holding property. In comparative example 1, no silica was added, the color dispersibility was poor, the three-dimensional effect was poor, and the effect of anti-darkening was somewhat low. The cosmetic retention is slightly reduced due to poor color dispersion.
Comparative example 2-comparative example 6 did not add hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, polysorbate-60, sorbitan isostearate, gellan gum, PEG-240/HDI copolymer bis-decyl tetradecyl polyether-20 ether, did not form jelly-like, and various properties were slightly degraded.
In comparative example 7, sodium calcium borosilicate, tin oxide, and the like were not added, the skin was dark, the skin secreted more grease, and the makeup retention was poor.
While the invention has been described with reference to certain preferred embodiments, it will be understood by those skilled in the art that various changes and substitutions of equivalents may be made and equivalents will be apparent to those skilled in the art without departing from the scope of the invention. Therefore, the protection scope of the present application shall be subject to the protection scope of the claims.
Claims (5)
1. A jelly-like eye shadow comprises the following components in percentage by mass:
0.5% -3% of aqueous thickener;
0.2% -1% of skin-moistening grease;
oil-in-water type emulsifier, 0.02-0.2%
0.02% -0.3% of stabilizer;
4% -6% of humectant;
65% -78% of water;
1% -2% of a first mica pearlescent mixture, wherein the first mica pearlescent mixture consists of mica, titanium dioxide and iron oxide black, and the mass ratio of the mica to the titanium dioxide to the iron oxide black is 43:7:50;
2% -3% of a second mica pearlescent mixture, wherein the second mica pearlescent mixture consists of mica, titanium dioxide and tin oxide, and the mass ratio of the mica to the titanium dioxide to the tin oxide is 34:65.5:0.5;
16% -17% of glass pearlescent mixture, wherein the glass pearlescent mixture is prepared from sodium calcium borosilicate: titanium white powder: tin oxide, sodium calcium borosilicate: titanium white powder: the mass ratio of the tin oxide is 87.9:10.7:1.4;
wherein, at least part of the surface of the titanium dioxide is wrapped by silica; the aqueous thickener comprises gellan gum, PEG-240/HDI copolymer di-decyl tetradecyl polyether-20 ether;
the aqueous thickener comprises 60% to 75% gellan gum, based on the total weight of the aqueous thickener; the mass ratio of the gellan gum to the PEG-240/HDI copolymer bis-decyl tetradecyl polyether-20 ether is (25-32): 50;
the oil-in-water type emulsifier comprises hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, polysorbate-60 and sorbitan isostearate; the mass ratio of the hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer to the polysorbate-60 to the sorbitan isostearate is (42-46): 2-4): 3.
2. The eye shadow of claim 1, wherein the mass ratio of gellan gum to PEG-240/HDI copolymer bis-decyltetradecylether-20 ether is 29.94:50.
3. the eye shadow of claim 1, wherein the mass ratio of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, polysorbate-60, sorbitan isostearate is 44:3:3.
4. The jelly-like eye shadow of claim 1 or 2, wherein the emollient oil is selected from the group consisting of dimethicone, ethyl macadamia nut oleate, hydrogenated cocoglycerides, glycerol laurate, isononyl isononanoate, hydrogenated polyisobutene, sunflower seed oil, safflower seed oil, jojoba oil, castor oil, coconut oil, grape seed oil, shea butter, white pool seed oil, macadamia nut oil, olive oil, palm oil, or a combination thereof; and/or the number of the groups of groups,
the humectant is selected from glycerol, propylene glycol, 1, 3-butanediol, trehalose, tremella polysaccharide, magnetitum, sodium hyaluronate or their combination; and/or the number of the groups of groups,
the stabilizer is selected from anhydrous calcium chloride, potassium laurate, magnesium sulfate, sodium chloride, potassium chloride, tromethamine, triethanolamine or a combination thereof.
5. Eye shadow according to claim 1 or 2, characterized in that the jelly-like eye shadow further comprises 0.5-1.5% of a powder dispersing agent and/or 0.02-0.3% of an antioxidant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211660883.XA CN115778847B (en) | 2022-12-23 | 2022-12-23 | Jelly-like eye shadow and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211660883.XA CN115778847B (en) | 2022-12-23 | 2022-12-23 | Jelly-like eye shadow and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115778847A CN115778847A (en) | 2023-03-14 |
CN115778847B true CN115778847B (en) | 2024-01-09 |
Family
ID=85427763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211660883.XA Active CN115778847B (en) | 2022-12-23 | 2022-12-23 | Jelly-like eye shadow and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115778847B (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002146237A (en) * | 2000-11-15 | 2002-05-22 | Arie:Kk | Novel color iris foil gloss pigment and cosmetic comprising the same |
KR20070081994A (en) * | 2006-03-21 | 2007-08-20 | 주식회사 엘지생활건강 | Cosmetic composition for make-up of stick-type providing refreshing feeling and pearl feeling and preparation method thereof |
CN107320395A (en) * | 2017-08-14 | 2017-11-07 | 上海欧润化妆品有限公司 | A kind of eye shadow and preparation method thereof |
CN107412115A (en) * | 2017-02-09 | 2017-12-01 | 苏州安特化妆品股份有限公司 | A kind of g., jelly-like foundation cream and preparation method thereof |
CN107737025A (en) * | 2017-10-27 | 2018-02-27 | 新时代健康产业(集团)有限公司 | A kind of velvet gel moisturizing eye shadow and preparation method thereof |
CN113520889A (en) * | 2020-04-21 | 2021-10-22 | 上海瀛彩生物科技有限公司 | Pearlescent eye shadow gel powder and preparation method thereof |
CN115300417A (en) * | 2022-09-16 | 2022-11-08 | 诺斯贝尔化妆品股份有限公司 | Sunscreen cream suitable for children and sensitive muscles and preparation method thereof |
-
2022
- 2022-12-23 CN CN202211660883.XA patent/CN115778847B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002146237A (en) * | 2000-11-15 | 2002-05-22 | Arie:Kk | Novel color iris foil gloss pigment and cosmetic comprising the same |
KR20070081994A (en) * | 2006-03-21 | 2007-08-20 | 주식회사 엘지생활건강 | Cosmetic composition for make-up of stick-type providing refreshing feeling and pearl feeling and preparation method thereof |
CN107412115A (en) * | 2017-02-09 | 2017-12-01 | 苏州安特化妆品股份有限公司 | A kind of g., jelly-like foundation cream and preparation method thereof |
CN107320395A (en) * | 2017-08-14 | 2017-11-07 | 上海欧润化妆品有限公司 | A kind of eye shadow and preparation method thereof |
CN107737025A (en) * | 2017-10-27 | 2018-02-27 | 新时代健康产业(集团)有限公司 | A kind of velvet gel moisturizing eye shadow and preparation method thereof |
CN113520889A (en) * | 2020-04-21 | 2021-10-22 | 上海瀛彩生物科技有限公司 | Pearlescent eye shadow gel powder and preparation method thereof |
CN115300417A (en) * | 2022-09-16 | 2022-11-08 | 诺斯贝尔化妆品股份有限公司 | Sunscreen cream suitable for children and sensitive muscles and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN115778847A (en) | 2023-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110946771A (en) | Water-containing oil-controlling loose powder and preparation method thereof | |
CN111096912B (en) | Bicontinuous phase type eye and lip makeup remover and preparation method thereof | |
CN111643401B (en) | Lipstick with high water content and preparation method thereof | |
DE112014001299T5 (en) | Cosmetic composition | |
CN105407870A (en) | Organogel composition and organogel mask pack produced by using same | |
CN104940044A (en) | Foundation cream with stable wire-drawing effect and preparation method of foundation cream | |
CN114028267B (en) | Oil-control make-up-fixing composition, water-containing honey powder and preparation method thereof | |
CN110507562B (en) | Light sensation concealer CC cream and preparation method thereof | |
KR20010072740A (en) | Solid aqueous gel comprising a hydrophilic gelling agent and starch, composition comprising same and uses | |
WO2017023691A1 (en) | Cosmetic compositions for minimizing skin imperfections | |
CN111568778B (en) | Three-layer essence with skin modification and nourishing effects, and preparation method and application thereof | |
CN109431839A (en) | A kind of moisturizing metallochrome lip gloss formula | |
CN112274438A (en) | Eyebrow-holding type correction cream and preparation method thereof | |
CN115778847B (en) | Jelly-like eye shadow and preparation method thereof | |
CN109199984B (en) | Whitening and skin-care composition capable of changing powder into cream and preparation method thereof | |
CN111419740A (en) | Efficient makeup holding powder base composition, preparation method thereof and efficient makeup holding powder base solution | |
JP5464587B2 (en) | Oil-in-water emulsified cosmetic | |
CN115400035A (en) | Pearlescent eye shadow and preparation method thereof | |
KR101684415B1 (en) | Cosmetic composition of water-in-oil with liposome hexacarboxymethyl dipeptide-12 and menufacturing method thereof | |
KR101472315B1 (en) | Eye liner of cream form cosmetic composition comprising hectorit and fine grinding pigment | |
KR101183068B1 (en) | The components of cosmetics with positive | |
CN116077364B (en) | Moisturizing concealer skin care product and preparation method thereof | |
JP6430789B2 (en) | Sunscreen cosmetics | |
KR20130055332A (en) | Uv protecting cosmetic composition having water splash appearance and a method of preparing thereof | |
CN115337249B (en) | Matte eye shadow and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |